Progyny, Inc. Files Definitive Proxy Statement (DEF 14A)

TL;DR

<b>Progyny, Inc. has filed its Definitive Proxy Statement (DEF 14A) for the fiscal year ending December 31, 2023.</b>

AI Summary

Progyny, Inc. (PGNY) filed a Proxy Statement (DEF 14A) with the SEC on April 12, 2024. Progyny, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 12, 2024. The filing covers the fiscal year ending December 31, 2023. Progyny, Inc. was formerly known as Auxogyn, Inc. The company's business address is 1359 Broadway, 2nd Floor, New York, NY 10018. The filing includes data related to stock awards and options for PEO and Non-PEO members for the years 2020-2023.

Why It Matters

For investors and stakeholders tracking Progyny, Inc., this filing contains several important signals. This DEF 14A filing provides detailed information on executive compensation, board of directors, and shareholder proposals, which are crucial for investors to understand governance and potential impacts on stock value. The inclusion of data on stock awards and options for PEO and Non-PEO members over several years (2020-2023) offers insights into the company's incentive structures and potential dilution.

Risk Assessment

Risk Level: low — Progyny, Inc. shows low risk based on this filing. The filing is a routine DEF 14A, providing standard disclosures on corporate governance and executive compensation, with no immediate red flags or significant new risks indicated.

Analyst Insight

Review the executive compensation details and shareholder proposals within the DEF 14A to assess potential impacts on corporate strategy and shareholder value.

Key Numbers

• 2024-04-12 — Filing Date (DEF 14A filing date)
• 2023-12-31 — Fiscal Year End (Reported fiscal year end)
• 2020-2023 — Data Range (Years covered for stock awards and options data)

Key Players & Entities

• Progyny, Inc. (company) — Filer name
• Auxogyn, Inc. (company) — Former company name
• 212-888-3124 (dollar_amount) — Business phone number
• 1359 Broadway (company) — Business street address
• New York (company) — Business city
• NY (company) — Business state
• 10018 (company) — Business zip code

FAQ

Industry Context

Progyny operates in the health and allied services sector, focusing on fertility and women's health benefits management.

Regulatory Implications

As a healthcare services company, Progyny is subject to various healthcare regulations, though this specific filing (DEF 14A) primarily concerns corporate governance and executive compensation.

What Investors Should Do

1. Analyze the compensation packages for named executive officers.
2. Review any shareholder proposals and the board's recommendations.
3. Examine the details of stock awards and options granted to PEO and Non-PEO members.

Key Dates

• 2024-04-12: Filing of DEF 14A — Provides detailed corporate governance and executive compensation information for the fiscal year 2023.

Year-Over-Year Comparison

This is the initial DEF 14A filing for the period ending December 31, 2023, providing updated information on corporate matters.

Filing Documents

• pgny-20240412.htm (DEF 14A) — 1032KB
• pgny-20240412_g1.jpg (GRAPHIC) — 60KB
• pgny-20240412_g2.jpg (GRAPHIC) — 29KB
• pgny-20240412_g3.jpg (GRAPHIC) — 25KB
• pgny-20240412_g4.jpg (GRAPHIC) — 24KB
• pgny-20240412_g5.jpg (GRAPHIC) — 502KB
• pgny-20240412_g6.jpg (GRAPHIC) — 318KB
• 0001551306-24-000077.txt (&nbsp;) — 3849KB
• pgny-20240412.xsd (EX-101.SCH) — 4KB
• pgny-20240412_def.xml (EX-101.DEF) — 5KB
• pgny-20240412_lab.xml (EX-101.LAB) — 7KB
• pgny-20240412_pre.xml (EX-101.PRE) — 4KB
• pgny-20240412_htm.xml (XML) — 92KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 22 DIRECTOR COMPENSATION 49

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 52 DELINQUENT SECTION 16(A) REPORTS 53 TRANSACTIONS WITH RELATED PERSONS 54 HOUSEHOLDING OF PROXY MATERIALS 55 OTHER MATTERS 56 i TABLE OF CONT E N T PROGYNY, INC. 1359 Broadway, 2 nd Floor New York, New York 10018 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held Virtually at https://edge.media-server.com/mmc/p/kcnnryrm o n May 23, 2024 at 3:00 p.m., Eastern Time Our board of directors is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders (the "Annual Meeting") of Progyny, Inc., a Delaware corporation, to be held virtually, via live webcast at https://edge.media-server.com/mmc/p/kcnnryrm , originating from New York, New York on Thursday, May 23, 2024 at 3:00 p.m., Eastern Time, and any adjournment or postponement thereof. Similar to last year, we have decided to hold a virtual Annual Meeting this year. Stockholders attending the virtual meeting will be afforded the same rights and opportunities to participate as they would at an in-person meeting. For the Annual Meeting, we have elected to furnish our proxy materials, including this proxy statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "Annual Report"), to our stockholders primarily via the internet. On or about April 12, 2024, we expect to mail to our stockholders a Notice of Internet Availability of Proxy Materials (the "Notice") that contains notice of the Annual Meeting and instructions on how to access our proxy materials on the internet, how to vote at the Annual Meeting, and how to request printed copies of the proxy materials. Stockholders may request to receive all future materials in printed form by mail or electronically by email by following the instructions contained in the Notice. A stockholder's election to receive proxy materials by mail or email will remain in effect until revoked. We encourage stockholders to take advantag

View Full Filing

View this DEF 14A filing on SEC EDGAR